B cell activation biomarkers as predictive factors for the response to rituximab in rheumatoid arthritis: A six‐month, national, multicenter, open‐label study - Concepedia

Concepedia

Publication | Closed Access

B cell activation biomarkers as predictive factors for the response to rituximab in rheumatoid arthritis: A six‐month, national, multicenter, open‐label study

154

Citations

15

References

2011

Year

Jérémie Sellam, Houria Hendel‐Chavez, Stéphanie Rouanet, Karim Abbed, Bernard Combe, Xavier Le Loët, Jacques Tébib, Jean Sibilia, Yassine Taoufik, Maxime Dougados,

Arthritis & Rheumatism

Abstract

The presence of RF or anti-CCP antibodies and elevated IgG are 2 simple biomarkers that can be used routinely before therapy to predict response to rituximab in patients with refractory RA.

References

	Year	Citations

Page 1